FL S0596

Requires all health care practitioners to report any personal benefits received from pharmaceutical companies to the Department of Health, with quarterly updates including the nature, value, and purpose of each benefit

Defines "personal benefit" broadly to include investment interests, gifts, financial incentives, kickbacks, speaking fees, sponsored travel, research funding, free samples, and any other compensation received outside the practitioner-patient relationship

Mandates the Department of Health create uniform reporting procedures and a publicly accessible online database searchable by practitioner name, pharmaceutical company, or type of benefit

Requires the Auditor General to conduct annual audits to monitor compliance, verify data accuracy, and identify conflicts of interest

Establishes penalties including disciplinary action by licensing boards for first violations, with second or subsequent violations constituting a first-degree misdemeanor